The worst Ebola outbreak ended in 2016 after infecting more than 28,000 people and killing about 11,300 people worldwide.
This outbreak forced the medical experts to consider some serious action to overcome the disease, including establishing of trial vaccines to avoid the disease.
Now it appears that those vaccines are managing showing some promising data as several experts have found an Ebola vaccine is safe for children as well as adults and produces an immune response.
Discussing the vaccine, Prof. Sanjeev Krishna, of St George’s University of London’s Institute of Infection and Immunity, said,
“An unprecedented Ebola outbreak demonstrated how it’s possible for academics, non-governmental organizations, industry, and funders to work well together rapidly in times of medical crisis. The results of the trial show what sort of vaccine could best be utilized to deal with this awful disease effectively.”
“We are in need of something of specialists, medical experts, and organizers that maintain vigilance against outbreak diseases like Ebola. We ought to continue to improve ways to make, assess and deliver vaccines when they may be needed, often in parts of the world lacking in infrastructure for diagnosing infections and providing treatments.”
The first known human cases of Ebola occurred in 1976 during two simultaneous outbreaks in Sudan and the Democratic Republic of Congo, which sickened more than 600 people, based on the World Health Organization.
This vaccine can be really helpful for a country like India, who didn’t see an outbreak of Ebola. Though an Indian national coming back from Liberia do test positive for the fatal virus and was quarantined at a special facility at Delhi airport.
The vaccine contains a noninfectious part of a gene from the Zaire Ebola virus.
Furthermore, lower vaccine doses are highly recommended when boosting people with pre-existing antibodies to Ebolavirus glycoprotein, a discovering that has emerged following the vaccine was tested in a country that has experienced Ebola virus outbreaks before.
The vaccine was 1 of 2 being examined as a ‘candidate’ option by the World Health Organisation to recognize urgently a vaccine to combat the Ebola virus outbreak in West Africa.
But the outbreak is coming to an end slowly and steadily as in July, World Health Organisation (WHO) did declare the end of the Ebola virus disease in Congo.